State Street (NTLA) stake: 9.23M Intellia Therapeutics shares in 13G filing
Rhea-AI Filing Summary
Intellia Therapeutics, Inc. (NTLA) reports that State Street Corporation has filed as an institutional holder of its common stock. State Street reports 9,234,987 shares beneficially owned, representing 6.8% of the outstanding common stock as of the reporting date. It has shared voting power over 8,907,136 shares and shared dispositive power over 9,234,987 shares, with no sole voting or dispositive power. The holding is reported on behalf of State Street and certain investment advisory subsidiaries, including SSGA Funds Management, Inc. and State Street Global Advisors entities.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 9,234,987 shares
Percent of class: 6.8%
Shared voting power: 8,907,136 shares
+3 more
6 metrics
Beneficial ownership
9,234,987 shares
Shares of Intellia Therapeutics common stock reported as beneficially owned by State Street Corporation
Percent of class
6.8%
Percentage of Intellia Therapeutics common stock class beneficially owned by State Street Corporation
Shared voting power
8,907,136 shares
Shares over which State Street has shared power to vote or direct the vote
Shared dispositive power
9,234,987 shares
Shares over which State Street has shared power to dispose or direct disposition
Sole voting power
0 shares
Shares over which State Street has sole power to vote or direct the vote
Sole dispositive power
0 shares
Shares over which State Street has sole power to dispose or direct disposition
Key Terms
beneficially owned, shared voting power, shared dispositive power, Schedule 13G
4 terms
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 9234987.00"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Schedule 13G regulatory
"If a parent holding company has filed this schedule, pursuant to (ii)(G)"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What dispositive power does State Street hold over Intellia Therapeutics (NTLA) stock?
State Street reports shared dispositive power over 9,234,987 shares of Intellia Therapeutics and no sole dispositive power, meaning decisions to sell or otherwise dispose are held on a shared basis.
Which State Street subsidiaries are associated with the Intellia Therapeutics (NTLA) holdings?
The filing associates the holdings with SSGA Funds Management, Inc. and several State Street Global Advisors entities, including Europe Limited, Limited, Trust Company, and Ltd., each classified as investment advisers (IA).